151 results on '"Rakusa, Martin"'
Search Results
2. Validation of Slovenian version of ADAS-Cog for patients with mild cognitive impairment and Alzheimer's disease
3. How green facades affect the perception of urban ambiences : Comparing Slovenia and the Netherlands
4. Vpliv ozelenjenih fasad na zaznavanje urbanih okolij – primerjava med Slovenijo in Nizozemsko
5. ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease
6. The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke
7. The COVID‐19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics.
8. The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective.
9. The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with Corticosteroids
10. Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial—BLOSSOM
11. Joint European Academy of Neurology–European Pain Federation–Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment
12. Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging.
13. Separating the Idea from the Action: A sLORETA Study
14. The 2022 European Postgraduate (Residency) Program in Neurology in an historical and international perspective
15. Sex steroid hormones and epilepsy: Effects of hormonal replacement therapy on seizure frequency of postmenopausal women with epilepsy—A systematic review.
16. Traumatic Brain Injury during the SARS-CoV-2 Pandemics in Slovenia: A Single Center Study
17. The diabetic brain and cognition
18. European survey of patient satisfaction in the treatment of cancer-related neuropathic pain
19. Cognitive impairment in people with epilepsy: Montreal Cognitive Assessment (MoCA) as a screening tool
20. The Importance of Subjective Cognitive Decline Recognition and the Potential of Molecular and Neurophysiological Biomarkers—A Systematic Review.
21. Brain Dynamics Underlying Preserved Cycling Ability in Patients With Parkinson’s Disease and Freezing of Gait
22. The European Academy of Neurology COVID‐19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID‐19
23. COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper
24. European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases
25. Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging
26. Cognitive Impairment in People with Epilepsy
27. EAN guidance for developing and reporting clinical practice guidelines on rare neurological diseases
28. Cancer-related neuropathic pain (CRNP) in Europe: What are the gaps in diagnosis and treatment from patients' perspective?
29. The Alzheimer's Disease Assessment Scale–Cognitive Subscale (ADAS‐Cog): Validation of Slovenian version for detecting mild cognitive impairment or Alzheimer's dementia
30. Standardisation of the Slovenian version of the Alzheimer’s Disease Assessment Scale – cognitive subscale (ADAS-Cog)
31. Validation of Slovenian version of ADAS-Cog for patients with mild cognitive impairment and Alzheimer's disease
32. Awakening to sleep disorders in Europe: Survey on education, knowledge and treatment competence of European residents and neurologists
33. Mapping of European activities on the integration of sex and gender factors in neurology and neuroscience.
34. European clinical practice recommendations on opioids for chronic noncancer pain – Part 2: Special situations*
35. European* clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain
36. Association of Cortical and Subcortical β-Amyloid With Standardized Measures of Depressive and Anxiety Symptoms in Adults Without Dementia
37. Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm
38. Nutrition status and eating habits of patients with mild cognitive impairment (MCI) or Alzheimer’s dementia (AD)
39. Lessons learned from people with neurological diseases at the time of COVID‐19: The EFNA‐EAN survey.
40. Diagnostic and Therapeutic Errors in Classical Trigeminal Neuralgia: a Multicenter Survey
41. A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: The NeuroCOVID‐19 Task Force of the European Academy of Neurology.
42. Gender issues during the times of COVID‐19 pandemic.
43. Primary prevention of COVID‐19: Advocacy for vaccination from a neurological perspective.
44. P1‐242: DIAGNOSIS OF PATIENTS WITH COGNITIVE IMPAIRMENT AND UNDETERMINED CEREBROSPINAL FLUID (CSF) RESULTS FOR ALZHEIMER'S DISEASE
45. Separating idea from the action: a standardized low-resolution brain electromagnetic tomography (sLORETA) study
46. Awakening European Neurology –Sleep Education in Neurology (SEN) survey (P1.021)
47. Aetiology of cognitive impairment in patients with inconclusive cerebrospinal fluid results for Alzheimer’s disease (P4.184)
48. Clock Drawing Test: A Simple Scoring System for the Accurate Screening of Cognitive Impairment in Patients with Mild Cognitive Impairment and Dementia
49. Separating the Idea from the Action: A sLORETA Study
50. DIAGNOSIS OF PATIENTS WITH COGNITIVE IMPAIRMENT AND UNDETERMINED CEREBROSPINAL FLUID (CSF) RESULTS FOR ALZHEIMER’S DISEASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.